Eton Pharmaceuticals (ETON) Asset Utilization Ratio (2020 - 2025)

Eton Pharmaceuticals has disclosed Asset Utilization Ratio across 6 years of filings, most recently posting 0.66 for Q4 2025.

• Asset Utilization Ratio for Q4 2025 came in at 0.66, down 5.92% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.66 (down 5.92% YoY), and the FY2025 annual result was 0.95, up 31.4% from the prior year.
• Asset Utilization Ratio came in at 0.66 for Q4 2025 at Eton Pharmaceuticals, up from 0.53 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 1.82 in Q1 2024 to a low of 0.41 in Q1 2025.
• The 5-year median for Asset Utilization Ratio is 0.72 (2022), against an average of 0.88.
• Across the five-year window, Asset Utilization Ratio soared 5397.33% in 2021 and sank 77.43% in 2025, its largest moves.
• Eton Pharmaceuticals' Asset Utilization Ratio stood at 0.81 in 2021, then advanced by 0.52% to 0.81 in 2022, then jumped by 110.81% to 1.71 in 2023, then slumped by 59.28% to 0.7 in 2024, then dropped by 5.92% to 0.66 in 2025.
• The last three Asset Utilization Ratio figures came in at 0.66 (Q4 2025), 0.53 (Q3 2025), and 0.46 (Q2 2025), per Business Quant data.